Quick Answer
Bionano Genomics, Inc. reported Long-Term Debt of $0.00 for fiscal year 2021.
Bionano Genomics, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2021 | $0.00 | -100.0% |
| 2020 | $16.32M | — |
| 2019 | $0.00 | -100.0% |
| 2018 | $9.03M | — |
| 2017 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $0.00 | -100.0% | — |
| June 30, 2021 | $0.00 | -100.0% | -100.0% |
| March 31, 2021 | $14.87M | — | -8.9% |
| December 31, 2020 | $16.33M | — | +819.8% |
| September 30, 2020 | $1.77M | -90.5% | +0.0% |
| June 30, 2020 | $1.77M | -90.5% | — |
| December 31, 2019 | $0.00 | -100.0% | -100.0% |
| September 30, 2019 | $18.78M | +108.4% | +0.8% |
- Bionano Genomics, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Bionano Genomics, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 1, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: